Regeneron Pharmaceuticals Inc logo

Regeneron Pharmaceuticals Inc REGN

Market Closed
6 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
1,131. 50
-19.06
-1.66%
After Hours
$
1,132. 25
+0.51 +0.04%
98.44B Market Cap
24.52 P/E Ratio
0% Div Yield
616,600 Volume
42.79 Eps
$ 1,150.56
Previous Close
Day Range
1,128.97 1,152.87
Year Range
769.19 1,211.2
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
31 Oct 2024 (53 Days)
11.83
Cons. EPS
-
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
1 Aug 2024
10.61
Cons. EPS
11.56
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
2 May 2024
10.09
Cons. EPS
9.55
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
2 Feb 2024
10.73
Cons. EPS
11.86
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
2 Nov 2023
10.72
Cons. EPS
11.59
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
4 Nov 2016
2.71
Cons. EPS
3.13
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
4 Aug 2016
2.65
Cons. EPS
2.82
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
5 May 2016
2.58
Cons. EPS
2.57
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
9 Feb 2016
3.36
Cons. EPS
2.83
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
4 Nov 2015
3.2
Cons. EPS
3.47
EPS